Urolog. pro Praxi, 2009; 10(5): 302-304
Bladder cancer is the second-leading urological malignancy. It occurs in virtually all age categories, most commonly around sixty years of
age. Bladder tumours may be superficial, infiltrating, or metastatic. Intravesical instillation of BCG vaccine using ImmuCyst is one of the
methods used to treat superficial bladder tumours that are recurrent and very likely to progress to invasion (T1G3) and CIS.
Published: December 1, 2009 Show citation